124 related articles for article (PubMed ID: 22247013)
21. OCT4B-190 protects against ischemic stroke by modulating GSK-3β/HDAC6.
Chen Y; Wu Z; Zhu X; Zhang M; Zang X; Li X; Xu Y
Exp Neurol; 2019 Jun; 316():52-62. PubMed ID: 30981804
[TBL] [Abstract][Full Text] [Related]
22. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
Liedtke S; Stephan M; Kögler G
Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
[TBL] [Abstract][Full Text] [Related]
23. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
[TBL] [Abstract][Full Text] [Related]
24. Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours.
Rijlaarsdam MA; van Herk HA; Gillis AJ; Stoop H; Jenster G; Martens J; van Leenders GJ; Dinjens W; Hoogland AM; Timmermans M; Looijenga LH
Br J Cancer; 2011 Sep; 105(6):854-63. PubMed ID: 21847120
[TBL] [Abstract][Full Text] [Related]
25. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
[TBL] [Abstract][Full Text] [Related]
26. OCT4B expression in PBMNCs suggests the existence of an alternative OCT4 promoter.
Papamichos SI; Lambropoulos AF; Kotoula V
Genes Chromosomes Cancer; 2009 Dec; 48(12):1112-4. PubMed ID: 19760603
[No Abstract] [Full Text] [Related]
27. OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.
Atlasi Y; Mowla SJ; Ziaee SA; Gokhale PJ; Andrews PW
Stem Cells; 2008 Dec; 26(12):3068-74. PubMed ID: 18787205
[TBL] [Abstract][Full Text] [Related]
28. Induced overexpression of OCT4A in human embryonic stem cells increases cloning efficiency.
Tsai SC; Chang DF; Hong CM; Xia P; Senadheera D; Trump L; Mishra S; Lutzko C
Am J Physiol Cell Physiol; 2014 Jun; 306(12):C1108-18. PubMed ID: 24627557
[TBL] [Abstract][Full Text] [Related]
29. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
Asadi MH; Khalifeh K; Mowla SJ
J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
[TBL] [Abstract][Full Text] [Related]
30. Novel spliced variants of OCT4, OCT4C and OCT4C1, with distinct expression patterns and functions in pluripotent and tumor cell lines.
Malakootian M; Mirzadeh Azad F; Naeli P; Pakzad M; Fouani Y; Taheri Bajgan E; Baharvand H; Mowla SJ
Eur J Cell Biol; 2017 Jun; 96(4):347-355. PubMed ID: 28476334
[TBL] [Abstract][Full Text] [Related]
31. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos.
Cauffman G; Liebaers I; Van Steirteghem A; Van de Velde H
Stem Cells; 2006 Dec; 24(12):2685-91. PubMed ID: 16916925
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
[TBL] [Abstract][Full Text] [Related]
33. Novel Variant of OCT4, Named OCT4B5, is Highly Expressed in Human Pluripotent Cells.
Mehravar M; Poursani EM
Stem Cell Rev Rep; 2021 Jun; 17(3):1068-1073. PubMed ID: 33241484
[TBL] [Abstract][Full Text] [Related]
34. OCT4B regulates p53 and p16 pathway genes to prevent apoptosis of breast cancer cells.
Meng L; Hu H; Zhi H; Liu Y; Shi F; Zhang L; Zhou Y; Lin A
Oncol Lett; 2018 Jul; 16(1):522-528. PubMed ID: 29930717
[TBL] [Abstract][Full Text] [Related]
35. Distinctive expression pattern of OCT4 variants in different types of breast cancer.
Soheili S; Asadi MH; Farsinejad A
Cancer Biomark; 2017; 18(1):69-76. PubMed ID: 27814277
[TBL] [Abstract][Full Text] [Related]
36. All the Tested Human Somatic Cells Express Both Oct4A and Its Pseudogenes but Express Oct4A at Much Lower Levels Compared with Its Pseudogenes and Human Embryonic Stem Cells.
Xu G; Yang L; Zhang W; Wei X
Stem Cells Dev; 2015 Jul; 24(13):1546-57. PubMed ID: 25687509
[TBL] [Abstract][Full Text] [Related]
37. Spermatogonial stem cell self-renewal requires OCT4, a factor downregulated during retinoic acid-induced differentiation.
Dann CT; Alvarado AL; Molyneux LA; Denard BS; Garbers DL; Porteus MH
Stem Cells; 2008 Nov; 26(11):2928-37. PubMed ID: 18719224
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
39. OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer.
Gazouli M; Roubelakis MG; Theodoropoulos GE; Papailiou J; Vaiopoulou A; Pappa KI; Nikiteas N; Anagnou NP
Mol Carcinog; 2012 Feb; 51(2):165-73. PubMed ID: 21480394
[TBL] [Abstract][Full Text] [Related]
40. Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types.
Rodriguez RT; Velkey JM; Lutzko C; Seerke R; Kohn DB; O'Shea KS; Firpo MT
Exp Biol Med (Maywood); 2007 Nov; 232(10):1368-80. PubMed ID: 17959850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]